IMITA
LIVE

Serial Number

79303441

Owner

HELEN BELINDA WRAY

Filing Date

Nov 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

IMITA Trademark

Serial Number: 79303441 • Registration: 6661834

IMITA is a trademark filed by HELEN BELINDA WRAY on November 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

HELEN BELINDA WRAY

23 Kelvin Street

Entity Type: 98

Captix Biomedical Pty Ltd (2 trademarks)

c/- Integra Law,

Entity Type: 99

Trademark Details

Filing Date

November 3, 2020

Registration Date

March 8, 2022

Published for Opposition

December 21, 2021

Goods & Services

Bone implants comprising artificial materials; immuno-protective devices, namely, implants made of artificial materials; implantable medical devices, namely, medical, surgical and orthopaedic implants made of artificial materials; implantable medical devices with an immune-protective function, namely, implants consisting primarily of artificial materials and also including biological materials; implantable devices for the delivery of automatic medication, namely, implants consisting primarily of artificial materials; implantable devices for medical use in measuring the composition of body fluids; medical implants made of artificial materials; orthopaedic implants of artificial materials; artificial implants; medical apparatus and instruments for use in orthopaedic medical procedures; cell culture apparatus for medical use, namely, implantable cell culture chambers; drug delivery apparatus, namely, devices carrying cells for the delivery of drugs, implantable devices carrying cells for the delivery of drugs, cell cargo carriers for the delivery of drugs

Bone implants comprising living tissue; biological bone implant material comprising living tissue; surgical implants comprised of living tissues; cell therapies, namely, living cells for medical use, stem cells for medical use, endocrine progenitor cells for medical use; pharmaceutical preparations for restoration of endocrine function and metabolic control; pharmaceutical products for restoration of endocrine function and metabolic control; cells for medical use; cells for medical purposes; stem cells for medical purposes; endocrine progenitor cells for medical use; therapeutic medical drugs for restoration of endocrine function and metabolic control; preparations for medical purposes, namely, bone implants incorporating living cells for medical purposes

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Feb 6, 2023 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 8, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 8, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 8, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2022 R.PR
REVIEW OF CORRESPONDENCE COMPLETE
Jan 10, 2022 CORV
ASSIGNED TO PETITION STAFF
Jan 10, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 22, 2021 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 21, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 21, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Dec 19, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 1, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 1, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 1, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 17, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 20, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 19, 2021 TROA
REFUSAL PROCESSED BY IB
May 11, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 14, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 13, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 8, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2021 REPR